CEACAM5 and colorectal carcinoma: A fluorescent silica nanoparticle conjugated to an antibody targeting CEA is able to bind specifically to CRC cells via the antibody and is intended to be applied to fluorescent imaging in vivo for visualization of the tumor site for real-time surgical guidance, thus increasing the precision and success of surgery and improving prognosis [85].